AlphaYouJI
Congress trade
Sen. James Inhofe (R-OK) bought $15K-$50K of Biogen Inc. (NASDAQ) (BIIB) stock
James Inhofe, U.S. Senator (R-OK), disclosed a purchase of Biogen Inc. (NASDAQ) (BIIB) stock worth $15K-$50K in a STOCK Act filing on Jul 15, 2015.
The trade happened on Jul 9, 2015, 6 days before it was made public.
BIIB has moved -44.9% since the trade date, from $399.29 to $219.88 (Oct 2, 2026 close).
- Traded
- Jul 9, 2015
- Disclosed
- Jul 15, 2015
- Filing delay
- 6 days
- Price since
- -44.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (15)
- SellABT$50K-$100KJul 15, 2015
- BuyITC$50K-$100KJul 15, 2015
- BuyMRK$50K-$100KJul 15, 2015
- BuyCLR$15K-$50KJul 15, 2015
- SellMSACX$15K-$50KJul 15, 2015
- BuyPCLN$15K-$50KJul 15, 2015
- SellACSDX$1K-$15KJul 15, 2015
- BuyGE$1K-$15KJul 15, 2015
- SellMGEMX$1K-$15KJul 15, 2015
- SellNGIPX$1K-$15KJul 15, 2015
- BuyNGIPX$1K-$15KJul 15, 2015
- SellVADDX$1K-$15KJul 15, 2015
- SellVMIIX$1K-$15KJul 15, 2015
- SellVSMIX$1K-$15KJul 15, 2015
- SellWSTMX$1K-$15KJul 15, 2015
More BIIB insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.